Antiangiogenic effect of linomide on breast cancer VEGF transfectants

Oncology Reports

Volumn 4, Issue 1 SUPPL., 1997, Pages 253-256

  Ziche, Marina ^a   Gasparini, Giampietro ^b   Choudhuri, Rangana ^c   Bicknell, Roy ^c   Morbidelli, Lucia ^a   Parenti, Astrid ^a   Ledda, Fabrizio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b SAN BORTOLO HOSPITAL   (Italy)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Angiogenesis; Breast carcinoma; Endothelial cells; Linomide; VEGF

Indexed keywords

ANGIOGENESIS INHIBITOR; ROQUINIMEX; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; BREAST CANCER; CONFERENCE PAPER; CONTROLLED STUDY; CORNEA; ENDOTHELIUM CELL; FEMALE; GROWTH INHIBITION; HUMAN; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0031017641     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Horak ER, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, Greenall M, Stepniewska M and Harris AL: Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340: 1120-1124, 1992.
2. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S and Gasparini G: Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84: 1875-1887, 1992.
3. Toi M, Kashitani J and Tominaga T: Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer 55: 371-374, 1993.
4. Gasparini G, Weidner N, Bevilacqua P, Maluta S, Dalla Palma P, Caffo O, Barbareschi M, Boracchi P, Marubini E and Pozza F: Tumor microvessel density, p53 expression, tumor size and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma J Clin Oncol 12: 454-466, 1994.
5. Gasparini G and Harris AL: Clinical importance of the determination of tumor angiogenesis in breast cancer, much more than a new prognostic tool. J Clin Oncol 13: 765-782, 1995.
6. Fan T-P, Jaggar R and Bicknell R: Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy. Trends Pharmacol Sci 16: 57-66, 1995.
7. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1: 27-31, 1995.
8. Kalland T, Alm G and Stahhandske T: Augmentation of mouse natural killer cell activity by LS-2616, a new immunomodulator. J Immunol 134: 3956-3961, 1985.
9. Larsson E-L, Joki A and Stalhandske T: Mechanism of action of the new immunomodulator LS-2616 on T cell responses. Int J Immunopharmacol 9: 425-431, 1987.
10. Bengtsson M, Simonsson B, Carlsson K, Nilsson B, Smedmyr B, Termander B, Oberg G and Totterman TH: Stimulation of NK cell, T cell, and monocyte functions by the novel immunomodulator Linomide after autologous bone marrow transplanation. Transplantation 53: 882-888, 1992.
11. Kalland T: Effects of the immunomodulator LS-2616 on growth and metastasis of the murine B16-F10 melanoma. Cancer Res 46: 3018-3022, 1986.
12. Ichikawa T, Lamb JC, Chistensson PI, Hartley-Asp B and Isaacs JT: The antitumor effects of the quinoline-3-carboxamide Linomide on Dunning R-3327 rat prostatic cancers. Cancer Res 52: 3022-3028, 1992.
13. Vukanovic J, Passaniti A, Hirata T, Traystman RJ, Hartley-Asp B and Isaacs JT: Antiangiogenic effects of the quinoline-3-carboxamide Linomide. Cancer Res 53: 1833-1837, 1993.
14. Vukanovic J and Isaacs JT: Linomide inhibits angiogenesis, growth, metastasis, and macrophage infiltration within rat prostatic cancers. Cancer Res 55: 1499-1504, 1995.
15. Ziche M and Gullino PM: Angiogenesis and neoplastic progression in vitro. J Natl Cancer Inst 69: 483-487, 1982.
16. Ziche M, Alessandri G and Gullino PM: Gangliosides promote the angiogenic response. Lab Invest 61: 629-634, 1989.
17. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, Geppetti P and Ledda F: Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by Substance P. J Clin Invest 94: 2036-2044, 1994.
18. Zhang H-T, Craft P, Scott PAE, Ziche M, Weilch HA, Harris AL and Bicknell R: Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. J Natl Cancer Inst 87: 213-219, 1995.
19. Schelling ME, Meininger CJ, Hawker JR and Granger HJ: Venular endothelial cells from bovine heart. Am J Physiol 254: 1211-1217, 1988.
20. Toi M, Hoshima S, Takayanagi T and Tominaga T: Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res 85: 1045-1049, 1994.
21. Toi M, Kondo S, Suzuki H, Yamamoto Y, Inada K, Imazawa T, Taniguchi T and Tominaga T: Quantitative analyses of vascular endothelial growth factor in primary breast cancer. Cancer Res 77: 1101-1105, 1996.
22. v integrins. Science 270: 1500-1502, 1995.